首页> 外文期刊>Respiratory care >Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia
【24h】

Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia

机译:半定量降钙素原试验和常见生物标志物对社区获得性肺炎临床结果的预测价值

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The semi-quantitative serum procalcitonin test (Brahms PCT-Q) is available conveniently in clinical practice. However, there are few data on the relationship between results for this semi-quantitative procalcitonin test and clinical outcomes of community-acquired pneumonia (CAP). We investigated the usefulness of this procalcitonin test for predicting the clinical outcomes of CAP in comparison with severity scoring systems and the blood urea nitrogen/serum albumin (B/A) ratio, which has been reported to be a simple but reliable prognostic indicator in our prior CAP study. METHODS: This retrospective study included data from subjects who were hospitalized for CAP from August 2010 through October 2012 and who were administered the semiquantitative serum procalcitonin test on admission. The demographic characteristics; laboratory biomarkers; microbiological test results; Pneumonia Severity Index scores; confusion, urea nitrogen, breathing frequency, blood pressure, ≥ 65 years of age (CURB-65) scale scores; and age, dehydration, respiratory failure, orientation disturbance, pressure (A-DROP) scale scores on hospital admission were retrieved from their medical charts. The outcomes were mortality within 28 days of hospital admission and the need for intensive care. RESULTS: Of the 213 subjects with CAP who were enrolled in the study, 20 died within 28 days of hospital admission, and 32 required intensive care. Mortality did not differ significantly among subjects with different semi-quantitative serum procalcitonin levels; however, subjects with serum procalcitonin levels ≥ 10.0 ng/mL were more likely to require intensive care than those with lower levels (P <.001). The elevation of semi-quantitative serum procalcitonin levels was more frequently observed in subjects with proven etiology, especially pneumococcal pneumonia. Using the receiver operating characteristic curves for mortality, the area under the curve was 0.86 for Pneumonia Severity Index class, 0.81 for B/A ratio, 0.81 for A-DROP, 0.80 for CURB-65, and 0.57 for semi-quantitative procalcitonin test. CONCLUSIONS: The semi-quantitative serum procalcitonin level on hospital admission was less predictive of mortality from CAP compared with the B/A ratio. However, the subjects with serum procalcitonin levels ≥ 10.0 ng/mL were more likely to require intensive care than those with lower levels.
机译:背景:半定量血清降钙素原试验(Brahms PCT-Q)可在临床中方便地使用。但是,关于这种半定量降钙素原测试结果与社区获得性肺炎(CAP)临床结果之间关系的数据很少。我们调查了降钙素原蛋白测试与严重程度评分系统和血尿素氮/血清白蛋白(B / A)比率相比,预测CAP临床结果的有用性,据报道这是我们研究中简单但可靠的预后指标事先进行CAP研究。方法:这项回顾性研究包括从2010年8月至2012年10月因CAP住院治疗并在入院时进行半定量血清降钙素原试验的受试者的数据。人口特征;实验室生物标志物;微生物测试结果;肺炎严重程度指数评分;意识模糊,尿素氮,呼吸频率,血压,≥65岁(CURB-65)量表分数;并从他们的病历表中检索了入院时的年龄,脱水,呼吸衰竭,定向障碍,压力(A-DROP)量表分数。结果是入院后28天内的死亡率和重症监护的需要。结果:纳入研究的213名CAP受试者中,有20名在入院后28天内死亡,有32名需要重症监护。在半定量血清降钙素原水平不同的受试者中,死亡率没有显着差异。但是,血清降钙素原水平≥10.0 ng / mL的受试者比低水平的受试者更需要重症监护(P <.001)。在病因明确的受试者中,尤其是肺炎球菌性肺炎,更经常观察到半定量血清降钙素原水平的升高。使用死亡率的接收器工作特征曲线,曲线下面积对于肺炎严重程度指数类别为0.86,对于B / A比为0.81,对于A-DROP为0.81,对于CURB-65为0.80,对于半定量降钙素原试验为0.57。结论:与B / A比相比,入院时半定量血清降钙素原对CAP死亡率的预测性较低。但是,血清降钙素原水平≥10.0 ng / mL的受试者比水平较低的受试者更需要重症监护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号